UPDATE : Thursday, August 22, 2019
Off-label use of sirolimus for pediatric pulmonary vein stenosis banned
The government has banned the off-label use of sirolimus, an immunosuppress...
by Lee Hye-seon  |  2019-03-07 15:10
Amgen’s Xgeva solves adverse effect problems
Amgen’s Xgeva (ingredient: denosumab) has resolved adverse effect issues fo...
by Lee Han-soo  |  2019-03-07 14:25
‘Korean drugmakers can tap US generic market’
Korean pharmaceutical companies would find it better to utilize long-accumu...
by Jeong Sae-im  |  2019-03-07 11:54
Chinese partner to start trials for Genexine’s immunotherapeutic drug candidate
Genexine said Monday that I-Mab Biopharma, a Chinese bio-firm, has administ...
by Lee Han-soo  |  2019-03-06 14:27
Binex, Chongqing Zein to establish joint company
Binex said Wednesday that it has signed an agreement to establish a joint-v...
by Lee Han-soo  |  2019-03-06 13:41
Medytox keeps urging Daewoong to clarify suspicions over BTX’s origin
Medytox continued Tuesday to pressure Daewoong Pharmaceuticals to clarify s...
by Lee Han-soo  |  2019-03-05 16:22
Hanmi’s acute myeloid leukemia wins developmental stage orphan drug status
The Ministry of Food and Drug Safety has granted Hanmi’s HM43239, a treatme...
by Lee Han-soo  |  2019-03-05 15:34
Handok to market Amicus Therapeutics’ Fabry disease treatment
Handok said Tuesday that it has signed a local sales agreement with Amicus ...
by Lee Han-soo  |  2019-03-05 15:11
Lilly Korea to test rheumatoid arthritis drug for hair loss treatment
Lilly Korea is to conduct a clinical trial on rheumatoid arthritis drug Olu...
by Lee Hye-seon  |  2019-03-05 15:10
3rd-generation antiepileptic drug lands on Korea
Briviact(ingredient: brivaracetam), a third-generation antiepileptic treatm...
by Lee Hye-seon  |  2019-03-05 14:42
IVI gets $3.2 million for typhoid conjugate vaccine study in W. Africa
The International Vaccine Institute (IVI) said it has received a $3.2 milli...
by Lee Han-soo  |  2019-03-05 14:41
Hanmi releases P4 clinical trials for anti-hypertension treatment
Hanmi Pharmaceutical said Monday that it has published the results of phase...
by Lee Han-soo  |  2019-03-04 17:01
Regulator expands XGEVA’s indication for use by multiple myeloma patients
Amgen’s XGEVA (denosumab), a treatment for reducing possibilities of skelet...
by Kim Yun-mi  |  2019-03-04 16:02
AbbVie gets positive views for treatment of plaque psoriasis in EU
AbbVie said Monday that the European Medicines Agency's Committee for M...
by Lee Han-soo  |  2019-03-04 15:57
Qurient unveils P2a trial results for atopic dermatitis treatment in US
Qurient said Monday that it has presented the phase 2a clinical trial resul...
by Lee Han-soo  |  2019-03-04 14:16
US trade agency begins probe into Medytox’s complaint about Daewoong
Medytox said Monday that the U.S. International Trade Commission has starte...
by Lee Han-soo  |  2019-03-04 11:16
GC starts P1 trials of hemophilia treatment
GC said Thursday that it has administered the first dose of MG1113, a hemop...
by Lee Han-soo  |  2019-02-28 16:45
Bukwang to sell Novartis’ chronic hepatitis B treatment
Bukwang Pharmaceutical said Thursday that it has just begun domestic market...
by Lee Han-soo  |  2019-02-28 14:59
Chong Kun Dang topped clinical trials in 2018
Local drugmaker Chong Kun Dang won approval for clinical trials the most am...
by Lee Hye-seon  |  2019-02-28 10:50
Korea’s 30th novel drug K-Cab to get insurance benefit from March
Korea’s 30th novel medicine K-Cab Tab. (ingredient: tegoprazan) will receiv...
by Lee Hye-seon  |  2019-02-27 16:47
Back to Top